title: EMA greenlights second gene therapy.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000243:Adenosine Deaminase / Q000172:deficiency* / Q000235:genetics / Q000627:therapeutic use*; D000361:Agammaglobulinemia / Q000235:genetics / Q000628:therapy*; D017277:Drug Approval; D005060:Europe; D015316:Genetic Therapy / Q000331:legislation & jurisprudence* / Q000379:methods*; D006801:Humans; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000628:therapy*
chemical_list: D000243:Adenosine Deaminase